anonymous
Guest
anonymous
Guest
Brent Saunders had been at the helm of Allergan for about three years now. In that time the stock has gone from about $320 to less than $140. In between there have been major screw ups, like the failed Pfizer deal and the asinine sale of the Restasis IP to an Indian tribe. The man had $40 billion dropped on him by the dopes at Teva, mostly in cash, and he even screwed that up.
What will it take for this sub-moron to finally get the unceremonious boot to the curb he deserves?
What will it take for this sub-moron to finally get the unceremonious boot to the curb he deserves?